Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 5, 2025 • 6:00 PM ET

Date/Time Source News Release
12/30/2024 07:00 AM EST PR Newswire Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis
12/27/2024 09:00 AM EST PR Newswire Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock
11/14/2024 04:30 PM EST PR Newswire Precigen Reports Third Quarter 2024 Financial Results and Business Updates
11/12/2024 04:05 PM EST PR Newswire Precigen to Participate in the Stifel 2024 Healthcare Conference
09/16/2024 04:30 PM EDT PR Newswire Precigen to Participate in the 2024 Cantor Global Healthcare Conference
08/14/2024 04:05 PM EDT PR Newswire Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates
08/09/2024 08:00 AM EDT PR Newswire Precigen to Announce Second Quarter and First Half 2024 Financial Results on August 14th
08/07/2024 09:30 PM EDT PR Newswire Precigen Announces Pricing of $30.0 Million Public Offering of Common Stock
08/06/2024 04:04 PM EDT PR Newswire Precigen Announces Proposed $30 Million Public Offering of Common Stock
08/06/2024 04:01 PM EDT PR Newswire Precigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy Launch
Page

Additional News

As of January 5, 2025 • 6:00 PM ET

Date/Time Source News Release
01/02/2025 01:28 PM EST Zacks PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally?
12/27/2024 09:12 AM EST SeekingAlpha Precigen announces $79 million private placement offering of convertible preferred stock
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Precigen Inc.
11/14/2024 05:45 PM EST Zacks Precigen, Inc. (PGEN) Reports Q3 Loss, Lags Revenue Estimates
11/14/2024 04:53 PM EST SeekingAlpha Precigen GAAP EPS of -$0.09 misses by $0.01, revenue of $0.95M misses by $0.33M
11/13/2024 08:10 PM EST Zacks Alvotech (ALVO) Q3 Earnings and Revenues Beat Estimates
11/12/2024 08:35 AM EST Zacks Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Misses Revenue Estimates
11/06/2024 05:55 PM EST Zacks MaxCyte, Inc. (MXCT) Reports Q3 Loss, Tops Revenue Estimates
10/31/2024 08:15 AM EDT Zacks Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates
10/11/2024 08:00 AM EDT SeekingAlpha Patient Capital Management Q3 2024 Investment Review
Page